Connect with us

Technology

Abstrax Unveils Cutting-Edge Research on Flavor Compounds in Cannabis: Enhancing Breeding Programs with Deep Analytics

Published

on

Abstrax’s study links unique compounds to the distinctive cheese aroma in cannabis, while also revealing intense citrus and sulfuric scents from previously hidden compounds.

IRVINE, Calif., Sept. 3, 2024 /PRNewswire-PRWeb/ — Abstrax, a pioneer in botanical flavor technology, has published cutting-edge research uncovering new flavor compounds in cannabis. This research offers fresh insights into optimizing cannabis breeding programs through advanced chemical analysis and the innovative practice of chemohunting. Conducted in collaboration with 710 Labs and SepSolve Analytical, the published study reveals the significant impact of minor, non-terpenoid compounds, called flavorants, on the aroma profiles of cannabis varieties, even when the plants are genetically similar.

“Chemohunting and chemotyping are revolutionary because they provide the quantitative evidence breeders have long observed anecdotally. These practices empower breeders to make more accurate selections and deepen their understanding of plant traits.” – Twinkle Paryani, R&D at Abstrax

This research introduces chemohunting — a detailed approach to selective breeding that evaluates cannabis phenotypes based on their comprehensive chemical profiles, or “chemotypes.” This revelation promises to elevate the traditional practice of phenohunting from an art to an artisanal science, allowing breeders to achieve unprecedented consistency and innovation in cannabis cultivation.

“Within the cannabis industry, phenohunting – the process of selecting progeny from a cross of two parents – has traditionally been more of an art than a science,” said TJ Martin, Vice President of Research at Abstrax. “Cultivators typically grow thousands of seeds to identify plants with desired traits, such as growth vigor, pest resistance, and unique aromas. While growth characteristics can be visually monitored, selecting for aroma has been largely subjective. With chemotyping, we provide breeders with the analytical tools to select for specific chemical traits, transforming the breeding process from an art to a science.”

Twinkle Paryani, R&D Laboratory Chemist at Abstrax and the main author of the paper, further elaborated on the significance of these methods: “Chemohunting and chemotyping are revolutionary because they provide the quantitative evidence breeders have long observed anecdotally. These practices empower breeders to make more accurate selections and deepen their understanding of plant traits. They also offer valuable insights into the inheritance of specific properties without the high costs of sequencing, which can be a significant barrier for growers. As these methods become more widely available, ideally through testing labs, this knowledge will become accessible to everyone.”

One of the most significant discoveries was 3-mercaptohexyl hexanoate (3-MHH), a newly identified member of the tropicannasulfur compound (TCSC) family, which contributes to intense citrus and sulfurous aromas. Additionally, Abstrax notes for the first time in cannabis flower the presence of octanoic (OA) and decanoic acids (DA), linked to the sharp, pungent cheese aromas found in certain cannabis varieties.

Furthering their analysis, Abstrax discovered an inverse relationship between two flavorant classes—TCSCs and indole, the musty heterocycle that lends dank pungency to Chem-like varieties. This discovery allows breeders to effectively chemohunt for high-TCSC, low-indole phenotypes or vice versa, potentially redefining the team’s Exotic Cannabis Aroma Spectrum and offering a new language for consumers who are confused by traditional strain names.

“Our findings validate our previous research showing that minor, non-terpenoid compounds significantly influence the unique aroma characteristics of cannabis,” said Martin. “Even genetically similar cannabis phenotypes can exhibit a wide range of aromas, thanks to these lower concentration compounds. Ignoring them in routine analytical testing minimizes the usefulness of the data and misses out on vital information that can drive the cultivation of cannabis with specific, desirable traits.”

Kevin Koby, Chief Science Officer at Abstrax, emphasized the importance of incorporating these key volatile compounds in breeding programs. “Our results highlight the necessity of including flavorants in routine analytical testing to ensure consistency and specificity in cannabis breeding. This data-driven approach empowers breeders to optimize their growing programs, ensuring more consistent and novel cannabis experiences.”

The new chemical insights and methodologies derived from this study establish a foundation for advanced analytical testing in cannabis breeding programs. Abstrax plans to publish two white papers detailing these results and their applications, translating them into an easily digestible form for the broader cannabis industry. Consumer app and cannabis marketplace Weedmaps will also promote the publications to their audiences as a real-time way to educate consumers on the new era of cannabis cultivation and flavor experiences.

“We’re thrilled to support and promote Abstrax’s groundbreaking research,” says Boris Shcharansky, Vice President of Cannabis Advisory at Weedmaps. “This study is poised to significantly impact the cannabis industry by providing breeders with deeper insights and tools to refine their cultivation practices. The ability to target and enhance specific aroma profiles through advanced chemotyping is an exciting development that aligns with Weedmaps’ mission to connect consumers with the highest quality cannabis products.”

About Abstrax: Where Innovation and Science Meets Flavor Mastery

As the pioneering leader in the world of botanical flavor technology, Abstrax excels in crafting innovative terpene-driven, functional flavor solutions. Serving the cannabis, hops, flavor and fragrance industries, Abstrax is the trusted product development partner that forward-thinking CPG brands turn to when looking for a competitive edge. Founded in California by a team of award-winning PhD scientists, flavor chemists, and visionary product developers, Abstrax harnesses its three divisions to craft transformative CPG applications via innovative technology and more sustainable, all natural, and cost effective ingredients. Abstrax Tech produces groundbreaking peer reviewed research publications, discovers new flavor compounds, and produces terpene blends and flavors for tobacco, cannabis, and food applications – including botanically derived cannabis flavor experiences, live all-natural hemp-derived terpenes, and mood-enhancing terpene-flavor systems. Abstrax Labs offers cutting-edge R&D, extraction and analytical technologies through its proprietary Terplytics™ system. Its technology delivers the most advanced botanical testing for exploratory research, sensory quantification, strain validation, product development, and consumer insights. Abstrax Hops provides the most advanced research, products, and services that push the limits of brewing innovation. Its wide range of solutions encapsulates the authentic varietal-specific Hop Flavors, Dank Flavors, and next generation of advanced hop products including natural hop aroma extracts. Abstrax offers the utmost in safety, quality and regulatory adherence, ensuring seamless integration into product lines. Delve deeper with Abstrax at AbstraxTech.com, AbstraxHops.com and AbstraxLabs.com.

Media Contact

Abstrax PR, Abstrax, 1 2139258177, stacey@lavozmarketing.com, www.abstraxtech.com

View original content to download multimedia:https://www.prweb.com/releases/abstrax-unveils-cutting-edge-research-on-flavor-compounds-in-cannabis-enhancing-breeding-programs-with-deep-analytics-302236074.html

SOURCE Abstrax

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Media Advisory – Minister Hodgson to deliver keynote speech on One Year of Nation Building

Published

on

By

TORONTO, April 22, 2026 /CNW/ – The Minister of Energy and Natural Resources, the Honourable Tim Hodgson, will speak at the Empire Club of Canada regarding this past year’s accomplishments and future strategic directions.

Date: April 24, 2026

Time: 11:30 a.m. ET

All accredited media are asked to register using the Empire Club’s press accreditation and registration form. Details on how to participate will be provided upon registration.

Follow Natural Resources Canada on LinkedIn.

SOURCE Natural Resources Canada

Continue Reading

Technology

Harness Delivers Unified AI Intelligence Across Software Delivery with Google Cloud

Published

on

By

Harness integrates Google Cloud’s Developer Connect into its Software Delivery Knowledge Graph to give engineering teams smarter, faster AI-driven insights

SAN FRANCISCO, April 22, 2026 /PRNewswire/ — Harness, the AI Software Delivery Platform™ company, today announced that it will bring together Harness’s Software Delivery Knowledge Graph and Google Cloud’s Developer Connect. The initiative gives joint customers a unified, AI-ready view of their entire software delivery lifecycle, and the intelligence to act on it with confidence.

The announcement was made at Google Cloud Next, where Harness also won the 2026 Google Cloud Technology Partner of the Year Award in the Application Development – DevOps category.

The Missing Piece in AI Software Delivery

Modern software delivery environments are inherently complex. Pipelines, services, build and deploy infrastructure, artifacts, and dependencies are deeply interconnected — and the data that describes how they relate to one another is scattered across dozens of tools. As organizations accelerate their adoption of AI-powered engineering, that fragmentation becomes a critical liability. AI is only as effective as the context it can access, and today, most AI agents are operating with an incomplete picture.

Harness is addressing this challenge head-on. By integrating Google Cloud Developer Connect insights into the Harness Software Delivery Knowledge Graph, joint customers gain a continuously updated, relationship-aware model of their software delivery environment that spans both platforms, bridging the visibility gap between development and production so that AI agents can operate with complete and reliable context. For engineering teams, this translates directly to making decisions grounded in situational awareness rather than generic training data, allowing them to execute complex workflows with greater accuracy.

Where the Partnership Comes to Life

For joint customers of Harness and Google Cloud, this integration means Harness AI can now make smarter, faster decisions on their behalf. By bringing together deployment event logs, runtime data, and application dependency information from Google Cloud into the Harness Software Delivery Knowledge Graph, teams gain a continuously updated, comprehensive view of their software delivery environment. When an issue arises, engineers can diagnose and remediate faster, trace problems back to specific source files or infrastructure, and link artifacts to the teams responsible for them, without having to manually piece together context from multiple systems.

The result is AI that works harder for customers. With richer context available upfront, AI agents can operate more efficiently, delivering answers and recommendations that reflect the true state of the environment. Everything teams need is in one place, and their AI has everything it needs to act on it confidently.

Security is central to how this integration was built. Data shared between Harness and Google Cloud is governed by enterprise-grade access controls, ensuring the right information reaches the right people within the guardrails organizations require.

“AI is only as powerful as the context behind it. Without it, teams fall into the AI Velocity Paradox: moving code faster than ever, but risking shipping software that is unverified, insecure, and unreliable,” said Jyoti Bansal, co-founder and CEO of Harness. “This is exactly what our expanded work with Google Cloud directly addresses, giving joint customers a unified view of their software delivery environment and AI that can actually reason across it. When context is complete, speed and confidence go hand in hand.”

A Collaboration That Keeps Deepening

This integration is the latest evolution of a long-standing collaboration between Harness and Google Cloud. Harness AI runs on Gemini Enterprise Agent Platform, and joint customers already benefit from expanded access through Google Cloud Marketplace. With this announcement, that work expands from the infrastructure layer into the application layer — and directly into how AI understands and acts on the software delivery environment. And it doesn’t stop there. The Harness MCP Server is now accessible within Google’s Gemini Enterprise app environment, enabling Gemini Enterprise customers to leverage Harness capabilities directly from their existing AI interface.

“Google Cloud provides cutting-edge technology that helps partners innovate and deliver more impactful solutions for business transformation,” said Ritika Suri, Managing Director, AI and Data Partnerships at Google Cloud. “Through our partnership with Harness, we will provide customers with innovative capabilities that can improve operations, enhance customer experiences, and drive innovation.”

Join Us

As our Knowledge Graph ecosystem continues to grow, Harness remains committed to expanding the breadth of integrations available to customers with the goal of being the most comprehensive AI-ready software delivery platform on the market.

To connect with the Harness team in person, visit the Harness booth at Google Cloud Next.

About Harness
Harness is the AI Software Delivery Platform™ company, enabling engineering teams to build, test, and deliver software faster and more securely. Powered by Harness AI and the Software Delivery Knowledge Graph, the platform brings intelligent automation to every stage of the software delivery lifecycle after code — removing toil and freeing developers from manual, repetitive work. Companies like United Airlines, Morningstar, and Choice Hotels use Harness to deploy up to 70% faster, reduce change failure rates by 50%, cut deployment effort by 80%, and lower security noise by 65%. Based in San Francisco, Harness is backed by Menlo Ventures, IVP, Unusual Ventures, and Citi Ventures.

View original content to download multimedia:https://www.prnewswire.com/news-releases/harness-delivers-unified-ai-intelligence-across-software-delivery-with-google-cloud-302749850.html

SOURCE Harness

Continue Reading

Technology

H.I.G. Capital Announces the Sale of Celerion

Published

on

By

MIAMI, April 22, 2026 /PRNewswire/ — H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $74 billion of capital under management, is pleased to announce that one of its affiliates has signed a definitive agreement to sell its portfolio company, Celerion Holdings, Inc. (“Celerion” or the “Company”), a global CRO and leader in clinical pharmacology and bioanalytical sciences, to funds affiliated with THL Partners (“THL”).

Headquartered in Lincoln, Nebraska, Celerion is a leading provider of highly specialized clinical pharmacology and bioanalytical sciences with deep expertise in first-in-human dose escalation, cardiac safety (TQT), drug-drug interaction, and other complex clinical pharmacology studies that support regulatory approval and drug labeling. Celerion offers an integrated suite of services spanning data management, biostatistics, and clinical monitoring that supports a global base of pharmaceutical and biotechnology customers through its purpose-built clinical and laboratory infrastructure with facilities in Lincoln, Phoenix, Zurich, and Belfast.

H.I.G. acquired Celerion in November 2022 and worked closely with management to accelerate growth and strengthen the Company’s market position. During its ownership, H.I.G. supported strategic investments across commercial, operational, and technology initiatives, including the expansion of Celerion’s clinical and bioanalytical laboratory footprint. These efforts drove exceptional growth and solidified Celerion’s standing as a leading, clinical pharmacology-focused, contract research organization.

Susan Thornton, Celerion’s President & CEO, commented, “H.I.G. has been an exceptional partner to Celerion, helping us accelerate key strategic initiatives and invest meaningfully in our people, capabilities, and infrastructure. These efforts have strengthened our platform and enhanced the quality and consistency of outcomes we deliver to customers. We are excited to carry this momentum forward with THL as we enter our next phase of growth.”

Mike Gallagher, Managing Director at H.I.G., commented, “We are proud of what Celerion’s best-in-class team has accomplished during our partnership. The team has delivered industry- leading growth during our ownership, and we are confident it is uniquely positioned for its next chapter.”

Michael Kuritzky, Managing Director at H.I.G., added, “We are very proud of the work Celerion does to help drug sponsors worldwide navigate the complexities of clinical trial management. It has been a privilege to partner with Susan and her team, and we look forward to Celerion’s continued success.”

BofA Securities, Inc. and Lazard Frères & Co. LLC were financial advisors to H.I.G. and Celerion. McDermott Will & Schulte LLP was legal counsel for H.I.G. and Celerion in connection with the transaction.

About Celerion

Celerion is a clinical research organization that provides comprehensive clinical trial solutions to pharmaceutical and biotechnology clients conducting early clinical research throughout North America, Europe, and Asia. The Company serves its clients through a global network of facilities and provides first-in-human to proof-of-concept studies as well as bioanalytical laboratory services, data management and biometrics, and drug development services. For more information, visit celerion.com.

About H.I.G. Capital

H.I.G. Capital is a leading global alternative investment firm with $74 billion of capital under management.* Based in Miami, and with offices in Atlanta, Boston, Chicago, Los Angeles, New York, San Francisco, and Stamford in the United States, as well as international affiliate offices in Hamburg, London, Luxembourg, Madrid, Milan, Paris, Bogotá, Rio de Janeiro, São Paulo, Dubai, and Hong Kong, H.I.G. specializes in providing both debt and equity capital to middle market companies, utilizing a flexible and operationally focused/value-added approach:

H.I.G.’s equity funds invest in management buyouts, recapitalizations, and corporate carve-outs of both profitable as well as underperforming manufacturing and service businesses.H.I.G.’s debt funds invest in senior, unitranche, and junior debt financing to companies across the size spectrum, both on a primary (direct origination) basis, as well as in the secondary markets. H.I.G. also manages a publicly traded BDC, WhiteHorse Finance.H.I.G.’s real estate funds invest in value-added properties, which can benefit from improved asset management practices.H.I.G. Infrastructure focuses on making value-add and core plus investments in the infrastructure sector.

Since its founding in 1993, H.I.G. has invested in and managed more than 400 companies worldwide. The Firm’s current portfolio includes more than 100 companies with combined sales in excess of $53 billion. For more information, please refer to the H.I.G. website at hig.com.

*Based on total capital raised by H.I.G. Capital and its affiliates.

Contact:

Mike Gallagher
Managing Director
mgallagher@hig.com

Michael Kuritzky
Managing Director
mkuritzky@hig.com

Alex Zisson
Managing Director
azisson@hig.com

H.I.G. Capital
1450 Brickell Avenue
31st Floor
Miami, FL 33131
P: 305.379.2322
hig.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/hig-capital-announces-the-sale-of-celerion-302749396.html

SOURCE H.I.G. Capital

Continue Reading

Trending